The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
SENTINEL NODE MAPPING AND BIOPSY IN BREAST CANCER AND THEIR CLINICAL SIGNIFICANCE
Author(s): 
Pages: 633-635
Year: Issue:  5
Journal: JOURNAL OF GUANGXI MEDICAL UNIVERSITY

Keyword:  乳腺癌前哨淋巴结专利蓝99mTc-DX转移;
Abstract: 目的:研究乳腺癌前哨淋巴结的定位活检方法,探讨前哨淋巴结对腋窝淋巴结状态的预测价值及其临床意义.方法:对48例乳腺癌病人,采用专利蓝和99锝标记的大分子右旋糖苷(99mTc-DX)为示踪剂行前哨淋巴结显像,术中先进行前哨淋巴结定位活检,送快速冰冻病理检查,再作乳腺癌手术,全部病人均作腋窝淋巴结清扫.结果:48例病人中有44例找到前哨淋巴结,成功率91.7%.其中20例病人联合应用专利蓝和99mTc-DX两种方法定位前哨淋巴结,成功率100%.44例病人共找到前哨淋巴结(SLN)95个,病理检查36个有癌转移,非前哨淋巴结(NSLN)457个,病理检查73个有癌转移.44例病人中,SLN、NSLN均无转移25例,SLN、NSLN均有转移11例,SLN有转移但NSLN无转移7例,SLN未见转移但NSLN检测到癌转移1例.结论:SLN定位活检成功率高,联合应用专利蓝和99mTc-DX两种方法优于单用一种方法.SLN定位活检能较准确地预测腋窝淋巴结状态.SLN假阴性,或淋巴结跳跃性转移,需要进一步研究.
Related Articles
loading...